Curiously, in cancer, DIS3 mutations have been found in MM and, at a lower percentage, in AML, while mutations in this gene have not been reported in the sequencing efforts ongoing in epithelial cancers, with hundreds of patient genomes screened as of today. This evidence concerns the gene DIS3 and cancer.